Dioxin and other aryl-hydrocarbon receptor (AhR) agonists (e.g., benzo(a)pyrene and 3-methylcholanthrene [3MC]) can enhance the progression of various cancers, including liver, skin, lung, and renal cancers21–23. This evidence concerns the gene AHR and cancer.